Co-Authors
This is a "connection" page, showing publications co-authored by Anton Simeonov and Catherine Chen.
Connection Strength
0.580
-
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Front Pharmacol. 2020; 11:592737.
Score: 0.231
-
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS Pharmacol Transl Sci. 2021 Jun 11; 4(3):1124-1135.
Score: 0.059
-
Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics. Sci Rep. 2021 03 24; 11(1):6725.
Score: 0.059
-
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection. Bioorg Med Chem Lett. 2021 05 15; 40:127906.
Score: 0.058
-
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2. Nat Biotechnol. 2021 06; 39(6):747-753.
Score: 0.058
-
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules. ACS Infect Dis. 2021 06 11; 7(6):1389-1408.
Score: 0.057
-
Synergistic and Antagonistic Drug Combinations against SARS-CoV-2. Mol Ther. 2021 02 03; 29(2):873-885.
Score: 0.057